about
Estrogen receptor mutations and their role in breast cancer progressionDevelopment and validation of a novel platform-independent metastasis signature in human breast cancer.Targeted radiosensitization of ETS fusion-positive prostate cancer through PARP1 inhibition.Imaging in thoracic oncology: case studies from Multidisciplinary Thoracic Tumor Board (part 1 of 2 part series).Imaging in thoracic oncology: case studies from Multidisciplinary Thoracic Tumor Board: (part 2 of 2 part series).Racial/Ethnic Disparities in Genomic SequencingTargeted radiosensitization with PARP1 inhibition: optimization of therapy and identification of biomarkers of response in breast cancer.Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancer.Radiogenomics and radiotherapy response modeling.Postoperative Radiotherapy After Breast-Conserving Surgery for Early-Stage Breast Cancer: A Review.Pan-Cancer Analysis of Genomic Sequencing Among the Elderly.A comprehensive assessment of the prognostic utility of the Stephenson nomogram for salvage radiation therapy postprostatectomy.Breast cancer prevention using calcium and vitamin D: a bright future?Molecular Signatures of Radiation Response in Breast Cancer: Towards Personalized Decision-Making in Radiation Treatment.Circulating Tumors Cells as a Biomarker of Radiation BenefitAbstract 2055: Therapeutic resistance to BET bromodomain inhibition in prostate cancerPersonalisation of Radiotherapy for Breast CancerAbstract 3299: Maternal embryonic leucine zipper kinase is critical for the growth and migration of triple negative breast cancer cellsPARP-1 inhibitors and radiotherapy sensitivity: future prospects for therapy?Abstract 82: Novel role of DAPK-1 in growth regulation of ER-negative breast cancerAbstract 1664: Maternal embryonic leucine aipper kinase (MELK) is a critical regulator of proliferation and is independently prognostic in estrogen receptor-negative breast cancerAbstract 1665: Targeting phosphatases for the treatment of ER-negative breast cancerNovel Strategies for the Treatment of Estrogen Receptor-Negative Breast CancerTranscriptomic Heterogeneity of Androgen Receptor Activity Defines a de novo low AR-Active Subclass in Treatment Naïve Primary Prostate CancerComprehensive Transcriptomic Profiling Identifies Breast Cancer Patients Who May Be Spared Adjuvant Systemic TherapyRadioGx: A New Preclinical Tool to Model Intrinsic RadiosensitivityMutant P53 induces MELK expression by release of wild-type P53-dependent suppression of FOXM1PARP1 Inhibition Radiosensitizes Models of Inflammatory Breast Cancer to Ionizing RadiationA novel role for TTK in homologous recombination: implications for breast cancer radiosensitivity
P50
Q35599448-5595CC3E-AB11-4044-BC80-0F8244BDCA57Q35606889-2F704BD8-46CB-4142-B0AB-1A3D538FCCDFQ37285569-900C3593-AD5F-4A1D-87CA-309915453838Q37380518-AE6A2430-6815-4C2C-908E-6FED869EAB04Q37382440-A4DFD127-280F-42D7-AF3C-FA48BD31B96EQ37441661-4190D71B-7409-45C0-83E0-617D60A8DAF0Q38435441-4F035350-2456-4F79-AEDA-659D20EFE1CAQ38608844-6C05421A-9039-49C1-B7FF-BBDB8EA57D5BQ38665620-1E3C2AEF-83B1-4E3F-A7BC-B7598EC47DF3Q38848972-0C817017-5596-4556-AD8A-247F16F74541Q38929962-8977C7BB-D945-4FE4-9A15-74E0D19DDC04Q39096416-6FD19C9F-EDA0-4C70-898C-ED3651BEE7EFQ42589318-15DD47D9-09BF-4D55-AA65-6761B770D01FQ48214148-E9320E5C-BDC7-48B5-8401-540AE94EEB42Q63365995-1F0564E7-8966-42BE-8F58-35C6177C6E14Q63365999-A1009B9E-853D-4821-B463-578C4C416DD1Q63366005-CB09E963-C009-4BA9-A1F8-A4C597C795CAQ63366008-9A632C31-6D63-438E-88FB-79A65A6D45FBQ63366012-ADDD6EB9-C641-40A3-9CBA-B6AB51E75BF6Q63366016-F37DC1DD-4BAC-4801-837F-1857A0B5BC43Q63366021-54EDE733-64D1-428A-B1BE-7B661E3B1CDFQ63366027-13287774-6492-44F8-B484-6626F8E04A5BQ63366030-E0DA31D5-9274-479E-A58A-FFB980EB13F3Q90083932-0EA3F04E-9947-4F3C-A8ED-AECBEFE37775Q90315347-33E81CA8-B3D5-48FA-A8DF-5C0CC0FCC6CAQ91971716-5257FE4B-22FD-4998-BAC6-F901A48D0B40Q92465189-EDE7EF9D-4EED-4E02-B631-79F2E6AAF770Q92623697-5C6CD8CF-267C-421A-875A-5AE82A5F1199Q94547853-85A53EBD-9B3C-44E0-AF5F-0FE69C12D448
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Corey Speers
@ast
Corey Speers
@en
Corey Speers
@es
Corey Speers
@nl
Corey Speers
@sl
type
label
Corey Speers
@ast
Corey Speers
@en
Corey Speers
@es
Corey Speers
@nl
Corey Speers
@sl
prefLabel
Corey Speers
@ast
Corey Speers
@en
Corey Speers
@es
Corey Speers
@nl
Corey Speers
@sl
P106
P21
P31
P496
0000-0002-2362-2860